I check the morning light coming through the window, and then I check my mum. Before I even speak, I am already reading the signs.
Myeloma
A short course of ultra-low-dose radiation may relieve pain for many people with multiple myeloma who have uncomplicated bone lesions, with minimal side effects,…
New data from a long-term clinical trial show 10 of 20 people with hard-to-treat multiple myeloma are alive and free from disease progression five…
An arm of the European Medicines Agency (EMA) has recommended expanding the European approval of Johnson & Johnson‘s Tecvayli (teclistamab) to treat adults with…
I sit in the waiting room with a half-read magazine on my lap and realize that I haven’t turned a single page. The clock on…
I live in Southern California wine country. It’s harvest season here. Workers are plucking grapes from acres of vineyards, sending them off to the crush…
The U.S. Food and Drug Administration (FDA) has given GT Biopharma a green light to start a Phase…
I sit at the kitchen table late at night with a notebook open in front of me. My mum is asleep in the next room.
Artificial intelligence (AI) may help design better CAR T-cell therapies to treat myeloma and other cancers, a study showed. An AI-designed CAR…
“But you look great!” Have you ever heard some variation of that? I have. I confess, I’ve even said it. I think it’s a natural…
Recent Posts
- As a caregiver, I’ve learned to read my mum’s daily forecast
- Short radiation course may ease painful myeloma bone lesions
- Nearly 70% of those given approved myeloma therapy alive 5 years later
- Latest AACR progress report on myeloma is a superpower of good news
- FDA green lights first-in-human study of infusion leukemia treatment